The biotechnology sector has long stood at the intersection of innovation and financial fragility. While biotech companies drive some of the most consequential advances in medicine, spanning oncology, gene therapies, immunology, and rare diseases, they also face structural challenges that consistently undermine their ability to scale. Long development timelines, binary clinical outcomes, regulatory uncertainty, and […]
The post Biotech at a Crossroads, How Utility-Driven Digital Asset Treasuries Could Redefine Capital Access and Growth first appeared on The UCW Newswire : Financial, Business and Tech News.
HootDex Rolls Out EquiTrack Tokens as ComTrack Stack Expands Under Digital Asset Treasury Architecture 
What Commodity Markets Can Expect From the Trump‑Xi Summit 
Binance’s EU Crypto License Bid Faces Fresh Scrutiny After Reported Lagarde Intervention 
SEC and CFTC Say They Will Write Crypto Rules Without Congress 
SEC Opens Door for Crypto‑Style Trading of U.S. Stocks 
What We Actually Know About the Robinhood Staffers Accused of Profiting From Offshore Crypto Futures